BRCA2 Mutation trials recruiting in Massachusetts

All BRCA2 Mutation trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
  NCT06395519 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
  NCT06488378 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Prostate Cancer Genetic Risk Evaluation and Screening Study
  NCT05129605 · Phase: Not specified · Ages: 35 Years to 74 Years · Sex: Male · Massachusetts: Boston
• SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
  NCT04150042 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston